Reuters logo
BRIEF-Karolinska Development: Dilafor granted US patent for Phase II drug tafoxiparin
December 2, 2016 / 7:10 AM / a year ago

BRIEF-Karolinska Development: Dilafor granted US patent for Phase II drug tafoxiparin

Dec 2 (Reuters) - Karolinska Development AB :

* Says its portfolio company Dilafor AB, drug development company focusing on development of tafoxiparin for obstetric indications, has been granted U.S. patent protecting its proprietary compound tafoxiparin

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below